The future of the organization that oversees organ transplants in New Jersey is under threat after a federal investigation found “several egregious actions and potential violations,” including whistleblower accounts of an organ being harvested from a living patient and a cover-up of the evidence, according to a letter lawmakers sent to the organization’s CEO this week.

Experts on organ donations said the allegations are likely to have a ripple effect for organ transplant groups nationally.

The letter sent by the chairs of the U.S. House Ways and Means Committee to Carolyn Welsh, president and CEO of the New Jersey Organ and Tissue Sharing Network, or NJTO, questions whether the organization should keep its tax-exempt status. Losing it would mean NJTO would be shut down. According to fe

See Full Page